Allergan has introduced a new Hyaluronic acid (HA) filler that is said to both volumize and hydrate skin. Juvéderm Hydrate works like a regular HA filler; only it surpasses the level of standard skin hydration provided by its counterparts. According to a recent study presented at the 8th Anti-Aging Medicine World Congress in Monte Carlo, Monaco, Juvederm Hydrate could potentially set a new standard for skin-rejuvenation therapy.
HA is a common compound used in dermal fillers because of its sponge-life effect and watery consistency. The loss of the naturally occurring polysaccharide AH over time causes skin to look older from fine lines, wrinkles and folds.
Hyaluronic acid is a natural polysaccharide found in skin that has the property of retaining water, and this sponge-like effect is important in keeping the skin hydrated. Over time, the loss of HA results in older-looking skin that is characterized by static fine lines, wrinkles and folds.
According to Cosmetic Surgery Times:
“All of the currently available HA-based fillers, including Juvéderm, are composed of cross-linked HA. These aesthetic gels are useful in the treatment of fine lines and wrinkles not only because of their filling effect, but also because HA attracts water to it, resulting in fuller and smoother skin where injected. Juvéderm Hydrate, on the other hand, is composed of 13.5 mg/g uncross-linked HA and 0.9 percent mannitol, a formulation that results in a reduced free-radical degradation of HA where injected. This leads to extended longevity of the HA, allowing it to attract water over a longer period of time and ultimately improve the aesthetic outcomes of the filler treatment.”
A trial was recently conducted in France on the effects of Juvéderm Hydrate on 27 different women. The female patients, who had a mean age of 42.6 years, were injected in areas such as the eyes, cheeks, perioral and neckline. The patients’ skin was then assessed at days 15, 30 and 60. At 60 days, Juvéderm Hydrate proved to significantly hydrate the skin at the treated areas. Both doctor and patient satisfaction analysis reported that skin hydration, appearance, texture and brightness were “improved” in 90% of the patients. Furthermore, 80% of the patients treated saw “very improved” skin at day 60.
Of the patients surveyed, approximately 85 said they would recommend the treatment to their friend and undergo another treatment. Non-invasive approaches to skin rejuvenation are often preferred by patients due to cost and downtime. While Juvéderm Hydrate is currently available in England, Italy, France, Germany and Spain, there are no plans to submit it for FDA approval for the American market.
To Your Health & Beauty,
Vipul R. Dev, M.D.